HIV/AIDS (Treatment)

Do Women Respond Differently to HIV Therapy than Men?

Published in Women's Health Weekly, October 26th, 1998

In response to the limited availability of clinical data on women -- the fastest growing population infected with HIV -- Hoffmann-La Roche, Inc., has announced the first investigational study ever to examine the difference between men and women's response to anti-HIV therapy within the same study.

This study will evaluate and compare the response of women and men to the protease inhibitor Fortovase^TM (saquinavir) in combination with two nucleoside reverse transcriptase inhibitors (NRTIS) in HIV positive patients.

"This study is a critical step forward in better understanding the treatment of HIV/AIDS in women," said Carmen Zorrilla, MD,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1998-10-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry